Researchers at the University of Texas M. D. Anderson Cancer Center reported today that MK-0457 (VX-680), a novel multi-kinase inhibitor, is clinically active against multiple target mutations in two types of leukemia and myeloproliferative disorders, and produces few side effects for patients.
Scientists present findings from a 2005 field campaign during which they flew over Tropical Storm Gert to look at the storm inside and out to determine how Gert evolved. Presentation (poster A13A-0882) at the American Geophysical U nion meeting, at 4:40 p.m. EST, Dec. 11.
Scientists at the University of Leicester are to gain a greater insight into the workings of the human mind?through the study of a snail’s brain.
At the 2006 American Society for Cell Biology conference, scientists present the first research findings of a system that can pattern the formation of multiiple tissues from a single population of adult stem cells.
At the 2006 American Society for Cell Biology conference, scientists will report an increase in tumor frequency in mice with mutations in a cancer-associated gene, called Apc. This finding may contribute to scientific understanding about the epigenetic changes involved in colon cancer.
Alcohol is now the leading killer of Finnish adults in Finland, with consumption reaching an all time high last year in the Nordic nation, Finland health officials said.
Researchers are advancing against a rare, deadly lung disease (related to hormones) that no one had even heard of a decade ago. The disease targets only women, striking them down during their childbearing years. It can be triggered by pregnancy, progresses rapidly, and often results in death within 10 years.
The International Myeloma Foundation (IMF) — conducting research and providing education, advocacy and support for myeloma patients, families, researchers and physicians — today noted that multiple studies presented at the 2006 Annual Meeting of the American Society of Hematology (ASH) illustrate the breadth of the gains being made in the treatment of multiple myeloma and related blood cancers.
The popular hair-growth drug Propecia? taken by millions of balding men, artificially lowers the results of the prostate-specific antigen (PSA) test, the standard screening test for prostate cancer, researchers report.
Common blood pressure medications might help block the spread of pancreatic cancer, researchers at the Kimmel Cancer Center at Thomas Jefferson University in Philadelphia have found.